Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,377-2,388 of 4,306
Drug study icon
CompletedNCT02573701

Guideline vs Usual Treatment in Schizophrenic Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 12 Years to 17 Years
Countries
Sponsor
Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico
Condition
Schizophrenia
Other study type icon
CompletedNCT02655172

Have a Good Grasp of the Worldthe World

This summary needs review. Please check the official study record and contact the research team for details.

In Saint-Etienne
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Schizophrenia
Device study icon
CompletedNCT03774927

High Frequency rTMS Treatment for Cognitive Impairments in Chronic Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 60 Years
Countries
Sponsor
Beijing HuiLongGuan Hospital
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02390271

How Reducing Anxiety in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, AnxietyBehavioralFrom 18 Years to 65 Years
Countries
Sponsor
Institut de Recherche Biomedicale des Armees
Condition
Schizophrenia, Anxiety
Drug study icon
CompletedNCT00963846

Huperzine for Cognitive and Functional Impairment in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Biomedisyn Corporation
Condition
Schizophrenia
Other study type icon
TerminatedNCT01063335

Imaging Cannabinoid CB1 Receptors in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 55 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
Drug study icon
WithdrawnNCT03999190

Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 35 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
Drug study icon
CompletedNCT00206128

Switching From IR Seroquel to SR Seroquel for schizophrenia

This study is completed in the United States, in Australia, in Canada, .... It is testing Switching From IR Seroquel to SR Seroquel for schizophrenia.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Australia, Canada, ...
Sponsor
AstraZeneca
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.